The coming legalization of recreational marijuana is already increasing funding for studies, but regulations on such research have been slow to change.

The organ’s blood-pumping capacity improved with the infusion of cells, a study shows.

More than one-fifth of individuals treated with the genetically modified virus survived at least three years.

Preliminary data from Sarepta Therapeutics has exceeded expectations, causing a surge in company stock prices this week.

The use of pronuclear transfer to treat infertility must first be backed by evidence it can work in cases where parents seek to avoid mitochondrial mutations.

The cofounder of the EQUATOR Network devoted his career to boosting transparency and improving the quality of clinical research.

The first human experiment with neural precursor cells implanted to treat chronic spinal cord injury suggests the procedure is safe, and hints at a small benefit.  

As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull together real-world results.  

A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.